Evidence map›Paper›PMID 33970433›Full record

ReviewGeneral thoracic and cardiovascular surgery2021

Surgical considerations for atrial functional regurgitation of the mitral and tricuspid valves based on the etiological mechanism.

Toshihiko Shibata, Yosuke Takahashi, Hiromichi Fujii, Akimasa Morisaki, Yukio Abe

Open access · hybridAbstract readReview
In one paragraph

Review in General thoracic and cardiovascular surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Patch augmentationJournal of thoracic disease · 2022
    Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Toshihiko ShibataDepartment of Cardiovascular Surgery, Osaka City University Postgraduate of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, 545-5956, Japan. shibata-cvs@zeus.eonet.ne.jp.ORCID http://orcid.org/0000-0002-1241-5065
Yosuke TakahashiDepartment of Cardiovascular Surgery, Osaka City University Postgraduate of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, 545-5956, Japan.
Hiromichi FujiiDepartment of Cardiovascular Surgery, Osaka City University Postgraduate of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, 545-5956, Japan.
Akimasa MorisakiDepartment of Cardiovascular Surgery, Osaka City University Postgraduate of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, 545-5956, Japan.
Yukio AbeDepartment of Cardiology, Osaka City General Hospital, 2-13-22, Miyakojima Hondori, Miyakojima, Osaka, 534-0021, Japan.
Osaka City University · JPOsaka City General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial functional mitral regurgitation is a hot research topic in the field of mitral valve disease. Atrial functional mitral regurgitation is distinctly different from ventricular functional mitral regurgitation. The surgical indications for atrial functional mitral regurgitation have not been well established because of the small amount of evidence gathered to date. Mitral annular plication with an artificial ring is an essential surgical procedure because dilatation of the mitral valve annulus is a main factor underlying this pathology. Most of these cases can be treated by mitral annuloplasty alone. However, additional procedures, such as application of artificial chordae to the anterior leaflet for pseudo-prolapse, and posterior leaflet augmentation with a pericardial patch, are required in advanced cases with a giant left atrium and extremely enlarged mitral annulus. Chronic atrial fibrillation causes enlargement of the right and left atria. This pathology is a bilateral atrioventricular valve disease (dual-valve disease). Therefore, the conventional guidelines of single-valve disease should not be applied. Although atrial functional tricuspid regurgitation is underappreciated, tricuspid annuloplasty should be considered for most patients to prevent future regurgitation. In addition to the mitral and tricuspid valve procedure, integrated surgical management, including plication of the atrium and left appendage closure, is required. This review summarizes the current considerations of surgical treatment for atrial functional regurgitation of the mitral and tricuspid valves based on the etiological mechanism.

Indexed as

Mitral Valve AnnuloplastyMitral Valve InsufficiencyTricuspid Valve InsufficiencyHeart AtriaHumansMitral ValveTricuspid ValveAtrial functional regurgitationDual-valve diseaseSurgical indicationValve repair

Identifiers

PMID33970433
PMCPMC8203518
OpenAlexW3163588418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.